[µ¿Á¤] ±èÁ¾¿À ¿µ³²´ë ¾à´ë±³¼ö, °úÇбâ¼ú¿ì¼ö³í¹®»ó
±èÁ¾¿À ¿µ³²´ë ¾à´ë ±³¼ö°¡ Á¦34ȸ °úÇбâ¼ú¿ì¼ö³í¹®»óÀ» ¼ö»óÇß´Ù. Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ¿Í °úÇбâ¼úÁ¤º¸Åë½ÅºÎ°¡°¡ ÁÖ°üÇÏ´Â °úÇбâ¼ú¿ì¼ö³í¹®»óÀº âÀÇÀûÀÎ ¿¬±¸È°µ¿À» ÅëÇØ ¿ì¼öÇÑ ³í¹®À» ¹ßÇ¥ÇÑ °úÇбâ¼úÀÚ¿¡°Ô ¼ö¿©ÇÏ´Â ±¹³» °úÇбâ¼ú°èÀÇ ±ÇÀ§ ÀÖ´Â Çмú»óÀÌ´Ù. Çѱ¹¾àÁ¦ÇÐȸ¿¡¼ ÃßõÇÑ ±èÁ¾¿À ±³¼ö´Â 'Nanomedicine‑based commercial formulations: current developments and future prospects'³í¹®À¸·Î »óÀ» ¹Þ¾Ò´Ù.